Takeda & Protagonist submit FDA application for groundbreaking polycythemia vera therapy
The investigational subcutaneous hepcidin mimetic peptide is designed to regulate iron and red blood cell production
The investigational subcutaneous hepcidin mimetic peptide is designed to regulate iron and red blood cell production
WCK 5222 is the first New Chemical Entity (NCE) discovered and developed in India to be submitted for pan-European marketing authorisation
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
The resubmission of BLA for MOLBREEVI names Fujifilm as the drug substance manufacturer
If approved, imlifidase has the potential to transform the kidney transplant landscape by enabling highly sensitized patients to also have access to a potentially life-changing kidney transplant
If cleared by regulators, CagriSema would become the first treatment to combine a GLP-1 receptor agonist and a long-acting amylin analogue in a single injection
This partnership strengthens LMS as a leading CDMO supplier of peptide materials for both innovator and generic markets
The investigational therapy uses SteadyTeq, a proprietary copolymer technology from Medincell designed to release olanzapine steadily over time
The agreement pairs Croda’s global footprint and “smart science” approach with Amino’s precision manufacturing capabilities
Centanafadine is a first-in-class norepinephrine, dopamine, and serotonin reuptake inhibitor
Subscribe To Our Newsletter & Stay Updated